Cervical cancer benefits from trabectedin combination with the ß-blocker propranolol: <i>in vitro</i> and <i>ex vivo</i> evaluations in patient-derived organoids.

Di Fonte, Roberta; Strippoli, Sabino; Garofoli, Marianna; Cormio, Gennaro; Serratì, Simona; Loizzi, Vera; Fasano, Rossella; Arezzo, Francesca; Volpicella, Mariateresa; Derakhshani, Afshin; Guida, Michele; Porcelli, Letizia; Azzariti, Amalia

Cervical cancer benefits from trabectedin combination with the ß-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids.

Di Fonte, Roberta; Strippoli, Sabino; Garofoli, Marianna; Cormio, Gennaro; Serratì, Simona; Loizzi, Vera; Fasano, Rossella; Arezzo, Francesca; Volpicella, Mariateresa; Derakhshani, Afshin; Guida, Michele; Porcelli, Letizia; Azzariti, Amalia.

Afiliação

Di Fonte R; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Strippoli S; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Garofoli M; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Cormio G; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Serratì S; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Loizzi V; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Fasano R; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Arezzo F; Unit of Obstetrics and Gynecology, Department of Interdisciplinary Medicine, Policlinico Hospital, "Aldo Moro" University of Bari, Bari, Italy.
Volpicella M; Department of Biosciences, Biotechnologies and Environment, University of Bari, Bari, Italy.
Derakhshani A; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Guida M; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Porcelli L; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Azzariti A; IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.